74 related articles for article (PubMed ID: 17942294)
1. Lobucavir-induced proliferative changes in mice.
Woicke J; Durham SK; Mense MG
Exp Toxicol Pathol; 2007 Nov; 59(3-4):197-204. PubMed ID: 17942294
[TBL] [Abstract][Full Text] [Related]
2. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.
Nesfield SR; Clarke CJ; Hoivik DJ; Miller RT; Allen JS; Selinger K; Santostefano MJ
Int J Toxicol; 2005; 24(5):301-11. PubMed ID: 16257850
[TBL] [Abstract][Full Text] [Related]
5. Studies evaluating the utility of N-methyl-N-nitrosourea as a positive control in carcinogenicity studies in the p53+/- mouse.
Hoivik DJ; Allen JS; Wall HG; Nold JB; Miller RT; Santostefano MJ
Int J Toxicol; 2005; 24(5):349-56. PubMed ID: 16257854
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the carcinogenic potential of ezetimibe using nonclinical data in a weight-of-evidence approach.
Halleck M; Davis HR; Kirschmeier P; Levitan D; Snyder RD; Treinen K; Macdonald JS
Toxicology; 2009 Apr; 258(2-3):116-30. PubMed ID: 19428931
[TBL] [Abstract][Full Text] [Related]
7. Analysis of chloroethane toxicity and carcinogenicity including a comparison with bromoethane.
Holder JW
Toxicol Ind Health; 2008 Nov; 24(10):655-75. PubMed ID: 19141570
[TBL] [Abstract][Full Text] [Related]
8. Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.
Yano BL; Hardisty JF; Seely JC; Butterworth BE; McConnell EE; Swenberg JA; Williams GM; Stebbins KE; Golllapudi BB; Eisenbrandt DL
Regul Toxicol Pharmacol; 2008 Jun; 51(1):53-65. PubMed ID: 18367300
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
Williams GM; Iatropoulos MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenicity of lifelong administration of capsaicin of hot pepper in mice.
Toth B; Gannett P
In Vivo; 1992; 6(1):59-63. PubMed ID: 1627743
[TBL] [Abstract][Full Text] [Related]
11. [Carcinogenic activity of some Soviet drug preparations].
Tsapenko VF; Boĭm TM; Osin'kovskaia ND; Rubenchik BL
Eksp Onkol; 1986; 8(3):75-6, 78. PubMed ID: 3720645
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of ferulic acid on 7,12-dimethylbenz[a]anthracene-induced skin carcinogenesis in Swiss albino mice.
Alias LM; Manoharan S; Vellaichamy L; Balakrishnan S; Ramachandran CR
Exp Toxicol Pathol; 2009 May; 61(3):205-14. PubMed ID: 18845425
[TBL] [Abstract][Full Text] [Related]
13. Mouse model of diethylnitrosamine-induced gastric cancer.
Binato M; Kruel Schmidt M; Silveira Volkweis B; Behrend Silva Ribeiro G; Isabel Edelweiss M; Ricachenevsky Gurski R
J Surg Res; 2008 Aug; 148(2):152-7. PubMed ID: 18456281
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study.
Fujii E; Kimura K; Mizoguchi K; Kato A; Takanashi H; Itoh Z; Omura S; Suzuki M
Toxicol Appl Pharmacol; 2008 Apr; 228(1):1-7. PubMed ID: 18355581
[TBL] [Abstract][Full Text] [Related]
15. Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity.
Williams GM
IARC Sci Publ; 1999; (146):185-202. PubMed ID: 10353388
[No Abstract] [Full Text] [Related]
16. [Carcinogenic effect of benz(alpha)pyrene and its combination with other hydrocarbons after their oral administration].
Il'nitskiĭi AP; Voronin VM; Solenova LG
Vopr Onkol; 1974; 20(10):71-5. PubMed ID: 4432411
[No Abstract] [Full Text] [Related]
17. [The carcinogenic activity of medicinal ozokerite and its constituents].
Ruchkovskiĭ BS; Borisiuk IuP; Tiktin IA
Vopr Onkol; 1970 May; 16(5):77-80. PubMed ID: 5450815
[No Abstract] [Full Text] [Related]
18. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
Yang Y; Ge JP; Zhou ZT
J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066
[TBL] [Abstract][Full Text] [Related]
19. Promotion potential of madder color in a medium-term multi-organ carcinogenesis bioassay model in F344 rats.
Yokohira M; Yamakawa K; Hosokawa K; Matsuda Y; Kuno T; Saoo K; Imaida K
J Food Sci; 2008 Apr; 73(3):T26-32. PubMed ID: 18387132
[TBL] [Abstract][Full Text] [Related]
20. Toxicity value for 3-monochloropropane-1,2-diol using a benchmark dose methodology.
Hwang M; Yoon E; Kim J; Jang DD; Yoo TM
Regul Toxicol Pharmacol; 2009 Mar; 53(2):102-6. PubMed ID: 19133308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
